Tilarginine Acetate Injection in a Randomized International Study in Unstable MI Patients With Cardiogenic Shock - TRIUMPH – Presented at ACC 2007

Description:

The goal of the trial was to evaluate treatment with the nitric oxide synthase (NOS) inhibitor tilarginine compared with placebo among patients with cardiogenic shock complicating acute myocardial infarction (MI).